Nomura Holdings’s Vor Biopharma VOR Stock Holding History

Nomura Holdings’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,075	Closed	-$29K	–	2419
2024 Q3	$29K	Buy	+2,075	New	+$37.8K	﹤0.01%	1473

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's VOR Position: Q4 2024 in Review

Nomura Holdings sold out of Vor Biopharma (VOR) in Q4 2024, closing a stake of 2,075 shares — an estimated $29K sold.

Nomura Holdings first reported a position in VOR in Q3 2024 and held it in 1 quarter. The position peaked at $29K in Q3 2024. 50 funds tracked by Wall St. Rank hold VOR as of Q4 2024.

Nomura Holdings reported no remaining Vor Biopharma position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 2,075 Vor Biopharma shares in Q4 2024, an estimated $29K.
Nomura Holdings first reported a position in Vor Biopharma in Q3 2024 and held it in 1 quarter.
Nomura Holdings's Vor Biopharma position peaked at $29K in Q3 2024.
50 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.